financetom
Business
financetom
/
Business
/
Why ADT Stock Is Down 7% Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why ADT Stock Is Down 7% Today
Nov 3, 2024 12:50 PM

ADT Inc ( ADT ) shares are trading lower by 6.5% to $7.36 during Monday’s session following the announcement of a proposed secondary public offering of 56 million shares and a concurrent 16 million share repurchase by selling shareholder Apollo Global Management.

What To Know: ADT earlier announced the pricing of a secondary public offering of 56 million shares of its common stock, held by entities affiliated with Apollo Global Management.

This offering is set to close on October 30, 2024, pending customary conditions. The underwriters will have a 30-day option to purchase an additional 8.4 million shares. ADT will not sell any shares or receive any proceeds from this offering.

Additionally, ADT plans to buy 16 million shares from the underwriters at the same price paid by them to the selling stockholders, as part of its $350 million share repurchase program.

The underwriters will not receive fees for these repurchased shares. The offering will be managed by Barclays, Citigroup, and BTIG, who will facilitate the sale of shares in various markets.

Read Also: Ford Enjoys Bullish Drive Ahead Of Q3 Earnings, Struggles To Break Through Higher Resistance Levels

Should I Sell My ADT Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Shares of ADT have gained 29.09% year to date. This compares to the average annual return of 0.06%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

ADT has a 52-week high of $8.25 and a 52-week low of $5.53.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly's Weight Loss, Diabetes Drug Now Available in US in All Doses After Shortage
Eli Lilly's Weight Loss, Diabetes Drug Now Available in US in All Doses After Shortage
Aug 5, 2024
06:20 AM EDT, 08/05/2024 (MT Newswires) -- Eli Lilly and Company's ( LLY ) weight loss drug Zepbound and diabetes treatment Mounjaro are now available in the US in all doses, according to the US Food and Drug Administration's updated drug shortage database. Mounjaro have been in shortage since as early as 2022, while Zepbound was added to the list...
Carlyle's Q2 profit misses estimates
Carlyle's Q2 profit misses estimates
Aug 5, 2024
NEW YORK, Aug 5 (Reuters) - Private equity firm Carlyle Group ( CG ) reported a larger-than expected 11.7% year-on-year drop in second-quarter distributable earnings on Monday, as record revenue from management and transaction fees did not offset a big drop in performance fees. The decline was due to Carlyle generating less cash from asset sales. This resulted in smaller...
BioNTech's Q2 Loss Widens, Revenue Declines
BioNTech's Q2 Loss Widens, Revenue Declines
Aug 5, 2024
06:29 AM EDT, 08/05/2024 (MT Newswires) -- BioNTech SE ( BNTX ) reported a Q2 loss Monday of 3.36 euros ($3.68) per diluted share, widening from a loss of 0.79 euros per share a year earlier. Analysts polled by Capital IQ expected a loss of 2.01 euros Total revenue for the quarter ended June 30 was 128.7 million euros, down...
'Bitcoin Development Company' MicroStrategy Plunges Almost 15% In Pre-Market: What's Going On?
'Bitcoin Development Company' MicroStrategy Plunges Almost 15% In Pre-Market: What's Going On?
Aug 5, 2024
In the wake of its second-quarter 2024 earnings report, MicroStrategy Inc. ( MSTR ) experienced a significant pre-market drop of 14.71% on Monday. What Happened: According to Benzinga Pro, MicroStrategy’s stock price took a hit, trading at $1,235.01 after closing at $1,447.99 on Friday, closely mirroring the recent 9.38% decline in Bitcoin (CRYPTO: BTC). The company’s investment strategy, which heavily relies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved